Absence of Middle East respiratory syndrome coronavirus in camelids, Kazakhstan, 2015

Emerging Infectious Diseases

Volumn 22, Issue 3, 2016, Pages 555-557

  Miguel, Eve ^a   Perera, Ranawaka A P M ^b   Baubekova, Almagul ^c   Chevalier, Véronique ^a   Faye, Bernard ^a,d   Akhmetsadykov, Nurlan ^c   Ng, Chun Yin ^b   Roger, François ^a   Peiris, Malik ^b  

^a CIRAD   (France)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c LLP Antigen Research and Production Enterprise Antigen   (Kazakhstan)

^d Food and Agriculture Organization of the United Nations Camel Project   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

BACTRIAN CAMEL; CAMELID; DROMEDARY; FEMALE; GEOGRAPHIC DISTRIBUTION; KAZAKHSTAN; LETTER; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PHENOTYPE; POPULATION SIZE; SEROPREVALENCE; VIRUS REPLICATION; ZOONOSIS; ANIMAL; CAMEL; CORONAVIRUS INFECTIONS; GEOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; SEROEPIDEMIOLOGY; TRANSMISSION; VIROLOGY;

ANIMALS; CAMELUS; CORONAVIRUS INFECTIONS; FEMALE; GEOGRAPHY; HUMANS; KAZAKHSTAN; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84958787001     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2203.151284     Document Type: Letter

References (10)

1. Reusken CB, Haagmans BL, Müller MA, Gutierrez C, Godeke GJ, Meyer B, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013;13:859-66. http://dx.doi.org/10.1016/S1473-3099(13)70164-6.
2. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013;18:pii=20574. http://dx.doi.org/10.2807/1560-7917.ES2013.18.36.20574.
3. Memish ZA, Cotten M, Meyer B, Watson SJ, Alsahafi AJ, Al Rabeeah AA, et al. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis J. 2014;20:1012-5.
4. Reusken CB, Messadi L, Feyisa A, Ularamu H, Godeke GJ, Danmarwa A, et al. Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis. 2014; 20:1370-4. http://dx.doi.org/10.3201/eid2008.140590.
5. Chan RW, Hemida MG, Kayali G, Chu DK, Poon LL, Alnaeem A, et al. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med. 2014;2:813-22. http://dx.doi.org/10.1016/S2213-2600(14)70158-4.
6. Chan SM, Damdinjav B, Perera RA, Chu DK, Khishgee B, Enkhbold B, et al. Absence of MERS-coronavirus in Bactrian camels, southern Mongolia, November 2014. Emerg Infect Dis. 2015;21:1269-71. http://dx.doi.org/10.3201/eid2107.150178.
7. World Organisation for Animal Health. Infection with coronavirus in camels, Iran [cited 2015 Oct 11]. http://www.oie.int/wahis_2/public/wahid.php/Reviewreport/Review?page_refer=MapFullEvent Report& breportid=16411.
8. Knoll EM, Burger P. The encounter between Bactrian and dromedary camels in Central Asia. In: Faye B, Konuspayeva G, editors. Camels in Asia and North Africa: interdisciplinary perspectives on their past and present significance. Vienna (Austria): Austrian Academy of Sciences Press. 2012. p. 27-33, photos p. 248-250.
9. Hemida MG, Perera RA, Al Jassim RA, Kayali G, Siu LY, Wang P, et al. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill. 2014;19:pii:20828. http://dx.doi.org/10.2807/1560-7917.ES2014.19.23.20828.
10. Crameri G, Durr PA, Barr J, Yu M, Graham K, Williams OJ, et al. Absence of MERS-CoV antibodies in feral camels in Australia: implications for the pathogen’s origin and spread. One Health. 2015;1:76-82.